As trials for COVID-19 treatments, like the drug Remdesivir, are already underway, researchers are hoping to avoid mistakes made during the West African Ebola epidemic, in which incomplete studies led to inconclusive results.
Awards and Accolades: April 2020
Philadelphia Eagles Owner Jeffrey Lurie Gives $1 Million to Penn Medicine Research to Fight COVID-19
PARP Inhibitor Drugs Can be “Tuned” for Better Killing of Tumor Cells
Philadelphia 76ers All-Star Joel Embiid, 76ers Managing Partner Josh Harris, and Co-Managing Partner David Blitzer Join Forces to Provide $1.3 Million to Penn Medicine for Critical Support of Health Care Workers Fighting COVID-19
Coronavirus Workers Too Essential to Isolate Share Their Stories
Mental Health During the COVID-19 Pandemic
Coronavirus Is Keeping Philly Medical Students Out of Hospitals, But They Are Still Contributing
Penn Researchers Help Develop Rapid At-Home COVID-19 Test
Is Your Shortness of Breath Anxiety or Coronavirus? Experts Explain.
More Americans Should Probably Wear Masks for Protection
